• Bone Mineral Density in Patients with Hepatic Glycogen Storage Diseases
• Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor alpha (LXRalpha) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1
• Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor α (LXRα) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1
• Drug fever caused by propofol in the intensive care unit
• Glucose-6-phosphatase and type 1 glycogen storage disease: some critical considerations
• Glycogen storage disease type Ia misdiagnosed as multiple acyl-coenzyme A dehydrogenase deficiency by mass spectrometry
• Liver microsomal transport of glucose-6-phosphate, glucose, and phosphate in type 1 glycogen storage disease
• Localisation of the gene for glycogen storage disease type 1c by homozygosity mapping to 11q
• Molecular diagnosis of type 1c glycogen storage disease
• Multiple transport protein defects in a patient with glycogen storage disease type 1: GSD 1b/1c beta
• Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c
• Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c
• Neutropenia and neutrophil dysfunction in glycogen storage disease type 1c
• New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system
• Ontogeny of the murine glucose-6-phosphatase system
• Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus, and hypercholesterolemia
• The gene for glycogen-storage disease type 1b maps to chromosome 11q23
• The human embryonic-fetal kidney endoplasmic reticulum phosphate-pyrophosphate transport protein
• Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene